Murali Ramanathan

Dr. Murali Ramanathan is a Professor in the Department of Pharmaceutical Sciences at the University at Buffalo's School of Pharmacy and Pharmaceutical Sciences. His research integrates pharmacometrics, metabolomics, and artificial intelligence to study neurodegenerative and autoimmune disorders.

Research focuses include multiple sclerosis biomarker discovery, drug metabolism modeling, and AI applications in pharmacometric analysis. Current projects examine metabolic vulnerabilities in multiple sclerosis, ketone body metabolism, and large language model applications in drug development.

Ramanathan's publications demonstrate expertise in computational approaches to pharmaceutical challenges, with recent work exploring lifestyle interventions in multiple sclerosis, drug absorption modeling, and AI-enhanced pharmacometric analysis. His research contributes to understanding metabolic dysregulation in neurological diseases.